Barclays »

Impact Biomedical shares owned by Barclays

Quarter-by-quarter ownership of Impact Biomedical shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Impact Biomedical

Tip: Access up to 7 years of quarterly data

All positions including Impact Biomedical held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Impact Biomedical by Barclays

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0k 1.1k 1.79

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Opt Put Option (QQQ)
Microsoft Corp Opt Call Option (MSFT)
Ishares Tr Opt Call Option (IWM)
Apple Opt Put Option (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Tesla Opt Put Option (TSLA)
Ishares Tr Fund (HYG)
Facebook Inc cl a (META)
Berkshire Hathaway (BRK.B)
Broadcom (AVGO)
Visa (V)
Alphabet Opt Put Option (GOOG)

View all positions for Barclays

Top funds holding Impact Biomedical

Jane Street
Hrt Financial
Bank of America Corporation
Barclays
Wells Fargo & Company
Group One Trading

View all funds holding Impact Biomedical